SeaPRwire DR.NOAH BIOTECH’s AI-driven ALS Medicine Receives U.S. FDA Approval for Phase 1 Clinical Trial IND
SeaPRwire China Medical System (00867) Released its 2024 Interim Results:Steady Increase in Revenue and Profit Compared with 2H 2023
SeaPRwire iXBROKER Expands into Asian, MENA, and South American Markets with New Features and Enhanced Security
